CLINICAL TRIAL

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial

Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to assess the feasibility, tolerability, and preliminary efficacy of psilocybin therapy for adults with chronic neuropathic pain and co-morbid treatment resistant depression.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2025-04-24
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

Centre for Addiction and Mental Health

Watch author

Topics and keywords

psilocybin Depression Chronic Pain Clinical Trial Randomized Controlled Trial Safety Clinical Trial Treatment Resistant Depression Chronic Pain Psilocybin 25 mg PEX010 RECRUITING

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11 The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-07 The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01 Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical Sciences · 2025-11-19 Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18